Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes

被引：0
|
作者：
Pamela C. Heaton
Vibha C. A. Desai
Christina M. L. Kelton
Swapnil N. Rajpathak
机构：
[1] University of Cincinnati Academic Health Center,Pharmacy Practice and Administrative Sciences, James L. Winkle College of Pharmacy
[2] HealthCore,Carl H. Lindner College of Business
[3] University of Cincinnati,undefined
[4] US Outcomes Research,undefined
[5] Merck & Co.,undefined
[6] Inc.,undefined
来源：
BMC Endocrine Disorders | / 16卷
关键词：
Sulfonylureas; Oral antihyperglycemic agents; Type 2 diabetes; Hospital readmissions;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Cardiovascular risk in the spectrum of type 2 diabetes mellitus
    Ahmed, Intekhab
    Goldstein, Barry J.
    MOUNT SINAI JOURNAL OF MEDICINE, 2006, 73 (05): : 759 - 768
  • [32] The safety of sulfonylurea therapy in type 2 diabetes: have we reached the practical limits of our evidence base?
    Jeffrey A. Johnson
    Diabetologia, 2015, 58 : 1 - 3
  • [33] The safety of sulfonylurea therapy in type 2 diabetes: have we reached the practical limits of our evidence base?
    Johnson, Jeffrey A.
    DIABETOLOGIA, 2015, 58 (01) : 1 - 3
  • [34] Efficacy and Safety of Lixisenatide in Japanese Patients with Type 2 Diabetes Insufficiently Controlled with Basal Insulin±Sulfonylurea: A Subanalysis of the GetGoal-L-Asia Study
    Seino, Y.
    Ikeda, Y.
    Niemoeller, E.
    Watanabe, D.
    Takagi, H.
    Yabe, D.
    Inagaki, N.
    HORMONE AND METABOLIC RESEARCH, 2015, 47 (12) : 895 - 900
  • [35] Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: a nested case-control study
    Abdelmoneim, A. S.
    Eurich, D. T.
    Gamble, J. M.
    Johnson, J. A.
    Seubert, J. M.
    Qiu, W.
    Simpson, S. H.
    DIABETES OBESITY & METABOLISM, 2014, 16 (01) : 22 - 29
  • [36] Canagliflozin in Conjunction With Sulfonylurea Maintains Glycemic Control and Weight Loss Over 52 Weeks: A Randomized, Controlled Trial in Patients With Type 2 Diabetes Mellitus
    Yale, Jean-Francois
    Xie, John
    Sherman, Stephen E.
    Garceau, Claude
    CLINICAL THERAPEUTICS, 2017, 39 (11) : 2230 - 2242
  • [37] Effects of the TCF7L2 and KCNQ1 common variant on sulfonylurea response in type 2 diabetes mellitus patients: a preliminary pharmacogenetic study
    Dianatshoar, Diba
    Alidaee, Tara
    Sarhangi, Negar
    Afshari, Mahdi
    Meybodi, Hamid Reza Aghaei
    Hasanzad, Mandana
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2022, 21 (01) : 133 - 139
  • [38] Effects of the TCF7L2 and KCNQ1 common variant on sulfonylurea response in type 2 diabetes mellitus patients: a preliminary pharmacogenetic study
    Diba Dianatshoar
    Tara Alidaee
    Negar Sarhangi
    Mahdi Afshari
    Hamid Reza Aghaei Meybodi
    Mandana Hasanzad
    Journal of Diabetes & Metabolic Disorders, 2022, 21 : 133 - 139
  • [39] Application of screening tools to detect risk of hospital readmission in elderly patients in Valencian Healthcare System (VHS) (Spain)
    Donate-Martinez, Ascension
    Garces Ferrer, Jorge
    Rodenas Rigla, Francisco
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2014, 59 (02) : 408 - 414
  • [40] Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin
    Evans, JMM
    Ogston, SA
    Emslie-Smith, A
    Morris, AD
    DIABETOLOGIA, 2006, 49 (05) : 930 - 936
12345